C131H131F3N36O10S — CID 158570745
3-anilino-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(2-phenylethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide (PubChem CID 158570745) has the molecular formula C131H131F3N36O10S and a molecular weight of 2458.79 g/mol. Its IUPAC name is 3-anilino-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(2-phenylethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide.
| Compound Name | 3-anilino-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(2-phenylethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide |
|---|---|
| PubChem CID | 158570745 |
| Molecular Formula | C131H131F3N36O10S |
| Molecular Weight | 2458.79 g/mol |
| Exact Mass | 2457.05 |
| IUPAC Name | 3-anilino-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-thiazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-(2-phenylethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide |
| SMILES | Cc1nc(C(F)(F)F)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)s1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)C1CCN(c2ncccn2)CC1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1-c1ccccc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1CCc1ccccc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1Nc1ccccc1 |
| InChI | InChI=1S/C30H30N6O2.C28H26N6O2.C27H26N8O2.C25H29N9O2.C21H20F3N7O2S/c37-30(24-9-5-4-8-23(24)12-10-21-6-2-1-3-7-21)34-27-19-31-35-28(27)29-32-25-13-11-22(18-26(25)33-29)20-36-14-16-38-17-15-36;35-28(22-9-5-4-8-21(22)20-6-2-1-3-7-20)32-25-17-29-33-26(25)27-30-23-11-10-19(16-24(23)31-27)18-34-12-14-36-15-13-34;36-27(25-21(7-4-10-28-25)30-19-5-2-1-3-6-19)33-23-16-29-34-24(23)26-31-20-9-8-18(15-22(20)32-26)17-35-11-13-37-14-12-35;35-24(18-4-8-34(9-5-18)25-26-6-1-7-27-25)31-21-15-28-32-22(21)23-29-19-3-2-17(14-20(19)30-23)16-33-10-12-36-13-11-33;1-11-26-18(21(22,23)24)17(34-11)20(32)29-15-9-25-30-16(15)19-27-13-3-2-12(8-14(13)28-19)10-31-4-6-33-7-5-31/h1-9,11,13,18-19H,10,12,14-17,20H2,(H,31,35)(H,32,33)(H,34,37);1-11,16-17H,12-15,18H2,(H,29,33)(H,30,31)(H,32,35);1-10,15-16,30H,11-14,17H2,(H,29,34)(H,31,32)(H,33,36);1-3,6-7,14-15,18H,4-5,8-13,16H2,(H,28,32)(H,29,30)(H,31,35);2-3,8-9H,4-7,10H2,1H3,(H,25,30)(H,27,28)(H,29,32) |
| InChIKey | HSAVCMLUNLTPME-UHFFFAOYSA-N |
| XLogP | 19.95 |
| TPSA | 561.48 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 181 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2458.79 |
| LogP ≤ 5 | 19.95 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 32 |